lg 100268 has been researched along with Complications of Diabetes Mellitus in 1 studies
LG 100268: a retinoid X receptor (RXR) selective compound; structure given in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| "peroxisome accumulation and hepatomegaly) than PPARgamma agonists." | 1.30 | The RXR agonist LG100268 causes hepatomegaly, improves glycaemic control and decreases cardiovascular risk and cachexia in diabetic mice suffering from pancreatic beta-cell dysfunction. ( Binz, JG; Brown, HR; Gaskill, BA; Lancaster, ME; Lenhard, JM; Lightfoot, RM; Paulik, MA; Sundseth, SS; Weiel, JE, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lenhard, JM | 1 |
| Lancaster, ME | 1 |
| Paulik, MA | 1 |
| Weiel, JE | 1 |
| Binz, JG | 1 |
| Sundseth, SS | 1 |
| Gaskill, BA | 1 |
| Lightfoot, RM | 1 |
| Brown, HR | 1 |
1 other study available for lg 100268 and Complications of Diabetes Mellitus
| Article | Year |
|---|---|
The RXR agonist LG100268 causes hepatomegaly, improves glycaemic control and decreases cardiovascular risk and cachexia in diabetic mice suffering from pancreatic beta-cell dysfunction.
Topics: Animals; Blood Glucose; Cachexia; Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus | 1999 |